Skip to main content

Media Relations

Our Press and Media Relations team offers the latest press releases and background information on a variety of topics as well as image material for download.

Integrated diagnostic solutions for critical care settings

We are committed to improving patient outcomes with innovative diagnostic solutions for acute care that allow the diagnosis, outcome prediction, and monitoring of patients with acute medical conditions.

SphingoTec is a privately held company with its headquarters in Hennigsdorf near Berlin and with a wholly-owned subsidiary in San Diego, USA. With a long history of biomarker discovery, development, and validation, SphingoTec develops and markets innovative in vitro diagnostics solutions for its respective novel and proprietary blood-based protein biomarkers. 

Our aspiration is to effectively translate scientific advancements into routine clinical practice. We develop biomarkers addressing diagnostically underserved critical care conditions such as sepsis, acute heart failure, acute kidney injury, and cardiogenic shock. On the Nexus IB10 point-of-care analyzer, clinicians can deploy a wide range of commonly used parameters in acute and critical care settings, making the analyzer a useful addition to intensive care units (ICU), and emergency departments (ED), and other near-patient settings.

Subscribe to our Newsletter

Follow the link below to subscribe to our Newsletter & receive updates on our company and products

Subscribe now

Contact our Press & Media Relations Team

Ruxandra Lenz

Head of Marketing & Communications

Contact

Dr. Ulrike Glaubitz

Senior PR Specialist

Contact

Latest News

11. April 2022
The implementation of two critical care biomarkers guides the application of a potential new drug candidate for the treatment of COVID-19 patients.
Read more
24. March 2022
New evidence supporting the use of innovative biomarkers in the early identification of organ dysfunction and risk stratification of cardiac surgery patients is reported.
Read more
17. March 2022
SphingoTec and Rivaara Labs today announced that they have entered into a multi-year distribution agreement for the commercialization of SphingoTec’s point of care diagnostic solutions in the Indian subcontinent.
Read more

Media Coverage

14. April 2022
A multi-center study led by the University Hospital Hamburg-Eppendorf (UKE) is evaluating one of the first personalized approaches for moderate to severe COVID-19 patients.
Read more
12. April 2022
Biomarker-guided trial led by University Hospital Hamburg-Eppendorf (UKE) opens new avenues for personalized medicine for the treatment of COVID-19.
Read more
19. October 2021
Serial entrepreneur and industry expert Dr. Andreas Bergmann explains his diagnostic strategy in an interview.
Read more

Watch our upcoming and latest Webinars on demand

Find out about the latest breakthroughs in clinical diagnostics and get valuable insights from international healthcare experts. To improve patient management in critical care settings, we have created a series of webinars that look at the latest diagnostic innovations and how they influence today's clinical practice. Click here to see all available Webinars.

09.06.2022

Personalized medicine in critical care – The potential of biomarkers to enhance treatment success in COVID-19

Speaker: Dr. Mahir Karakas, MD, MBA; University Medical Center Hamburg-Eppendorf, Hamburg

28.04.2022:

Using Proenkephalin as a Novel Biomarker to Estimate GFR

Speaker: Prof. Dr. Peter Pickkers, Radboud University, Nijmegen

31.03.2022

Point-of-care Diagnostics in the Emergency Department: Better Patient Management

Speaker: Prof. Salvatore Di Somma, MD PhD; University La Sapienza Rome

Press photos for download